The pooled analysis of different reports in the Oncomine database also revealed higher FUBP1 expression in liposarcoma, salivary gland adenoid cystic carcinoma, T-cell acute lymphoblastic leukemia, rectal mucinous adenocarcinoma, and ovarian serous cystadenocarcinoma than in normal controls (Supplementary Figure S5, p < 0.001). This evidence concerns the gene FUBP1 and ovarian serous cystadenocarcinoma.